Original cyclosporin A (CsA) derivatives bearing various alkylthio side chains at the sarcosine residue 3 (R configuration) and for the most potent and selective compounds a 4'-hydroxyl group at the Me-Leucine residue 4 were prepared in one or two steps from commercially available CsA. The [2-(dimethyl or diethylamino)-ethylthio-Sar](3)-[(4'-OH)MeLeu](4)-CsA derivatives 3k and 3l displayed potent in vitro anti-HIV-1 (IC(50) approximately 46 nM) and low immunosuppressive activities (IC(50)>or=1500 nM).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2003.09.042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.
Transplant Cell Ther
December 2024
Department of Pediatric Oncology and Transplantation, Alberta Children's Hospital, University of Calgary; Calgary, Alberta, Canada. Electronic address:
Current literature lacks details on the impact of pediatric chronic graft-versus-host disease (cGVHD) on long-term survivorship after allogeneic hematopoietic cell transplantation (HCT). Nonetheless, cGVHD remains a leading cause of post-transplant morbidity and mortality in children and adolescents, which is particularly relevant given the longer life-expectancy after HCT (measured in decades) compared to older adults. To address this knowledge gap, leaders of the Pediatric Transplant and Cellular Therapy Consortium convened a multidisciplinary taskforce of experts in pediatric cGVHD and HCT late effects known as RESILIENT after Chronic GVHD (Research and Education towards Solutions for Late effects to Innovate, Excel, and Nurture after cGVHD).
View Article and Find Full Text PDFA novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging.
Front Endocrinol (Lausanne)
October 2024
Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL, United States.
Diabetes treatment options have improved dramatically over the last 100 years, however, close to 2 million individuals in the U.S. alone live with type 1 diabetes (T1D) and are still dependent on multiple daily insulin injections and/or continuous insulin infusion with a pump to stay alive and no oral medications are available.
View Article and Find Full Text PDFImmunosuppressants in women with repeated implantation failure in assisted reproductive techniques: a systematic review and meta-analysis.
Rev Bras Ginecol Obstet
October 2024
Departamento de Ginecologia e Obstetrícia Faculdade de Medicina Universidade Federal de Goiás GoiâniaGO Brazil Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal de Goiás, Goiânia, GO, Brazil.
Article Synopsis
- The study aimed to evaluate the effectiveness of using immunosuppressants (prednisolone, prednisone, or cyclosporine A) alongside IVF/ICSI in patients experiencing repeated implantation failure compared to IVF/ICSI alone.
- A total of seven studies involving 2,829 patients were analyzed, revealing that cyclosporine A significantly improved implantation and clinical pregnancy rates, while prednisolone and prednisone showed no positive impact on live birth or miscarriage rates.
- The findings suggest that cyclosporine A could be beneficial for certain outcomes, but researchers advise caution due to the limited sample size; prednisolone and prednisone do not appear to enhance clinical outcomes in affected patients.
Evaluating the potential of non-immunosuppressive cyclosporin analogs for targeting Toxoplasma gondii cyclophilin: Insights from structural studies.
Protein Sci
October 2024
Department of Biotechnology, University of Verona, Verona, Italy.
Toxoplasmosis persists as a prevalent disease, facing challenges from parasite resistance and treatment side effects. Consequently, identifying new drugs by exploring novel protein targets is essential for effective intervention. Cyclosporin A (CsA) possesses antiparasitic activity against Toxoplasma gondii, with cyclophilins identified as possible targets.
View Article and Find Full Text PDFDisorders of potassium homeostasis after kidney transplantation.
World J Transplant
September 2024
School of Medicine, University of Toronto, Toronto M5C 2T2, Ontario, Canada.
Disturbances of potassium balance are often encountered when managing kidney transplant recipients (KTR). Both hyperkalemia and hypokalemia may present either as medical emergencies or chronic outpatient abnormalities. Despite the high incidence of hyperkalemia and its potential life-threatening implications, consensus on its management in KTR is lacking.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!